Skip to main content
. 2019 Dec 1;11(12):640. doi: 10.3390/pharmaceutics11120640

Figure 4.

Figure 4

Mean ± SD of TDL prostate concentration within 3–18 days after daily subcutaneous (SC) administration of raw TDL and TDL PSO SNEDDS. * Significantly different (p < 0.05) compared to raw TDL.